中药白芷防治骨质疏松性疼痛的机制探析

摘要/Abstract

摘要： 目的：探析白芷防治骨质疏松性疼痛（OPP）的中医理论机制。方法：基于中药药性理论及中医“不通则痛”致痛机理，结合“肠-骨轴”骨代谢调控模式，初步分析白芷的性状、性能及OPP的病因病机，并以此为基础阐释白芷防治OPP的作用机制。结果：OPP是由素体虚弱、后天调护失宜或外感风寒湿热之邪等所致阴阳气血失调、经脉运行不畅、骨络闭阻不通的一种全身慢性筋骨类疼痛。OPP主要病因包括禀赋与体质因素，年龄与性别因素，营养与运动因素；病机包括肾精亏虚，脾胃虚弱，血瘀气滞等。白芷可借自身药性功用如“辛温之性”散风寒湿、行气活血，“辛温芳香之性”和脾胃而发挥抗OPP的作用；白芷可通过靶向调控骨体相关经络等途径纠正机体阴阳气血不通引起的“不通”之病理状态，继而发挥抗OPP的作用；白芷亦可通过纠正“肠-骨轴”骨代谢调控模式紊乱发挥抗OPP作用。结论：“不通则痛”贯穿OPP发生发展过程的始终。白芷防治OPP具有确切的中医理论基础，为白芷防治OPP提供了中医临证依据。

关键词: font-size:medium, ">白芷；不通则痛；肠-骨轴；骨质疏松性疼痛；理论机制

Abstract: Objective：To analyze the theoretical mechanism of Chinese Herb Angelica dahurica preventing and treating osteoporotic pain (OPP). Methods： Based on Chinese herbal property theory and the pain mechanism of "stagnation leading to pain"， combined with the "gut-bone axis" pattern of metabolism regulation， to analyze the characteristics and functional properties of Angelica dahurica， and the etiology and pathogenesis of OPP， and to explain the mechanism of Angelica dahurica preventing and treating osteoporotic pain. Results： OPP is a kind of chronic pain of muscles and bones in the whole body， which is caused by weakness of the body， acquired maladjustment or exogenous wind， cold， damp and heat evil. The main causes of OPP include endowment and physical factors， age and gender factors， nutrition and sports factors. Pathogenesis includes deficiency of kidney essence， weakness of spleen and stomach， blood stasis and qi stagnation. Angelica dahurica can play an anti OPP role by virtue of its own medicinal functions， such as "the nature of pungent warmth" dispersing wind and cold dampness， promoting qi and blood circulation， "the nature of pungent warmth and fragrance "harmonizing the spleen and stomach. Angelica dahurica can correct the "blocked" pathological state caused by the blockage of yin， yang， qi and blood through targeted regulation of bone related meridians， and then play the role of anti OPP.Angelica dahurica can also play the anti OPP role by correcting the disorder of "intestinal bone axis" bone metabolism regulation mode.Conclusion："Stagnation leadingto pain" runs through the occurrence and development of osteoporotic pain. Angelica dahurica preventing and treating osteoporotic pain has exact traditional Chinese medicine theoretical basis， which provides traditional Chinese medicine clinical basis for Angelica dahurica preventing and treating OPP.

Key words: Angelica dahurica, Stagnation leading to pain, Gut-bone axis, Osteoporotic pain, Theoretical mechanism

中图分类号:

邱世明, 董万涛, 张杰, 赵张凯, 王剑虹, 常茹梦, 袁鹏, 刘静怡, 杨攀. 中药白芷防治骨质疏松性疼痛的机制探析[J]. 中国医药导刊, 2022, 24(9): 850-855.

QIU Shiming, DONG Wantao, ZHANG Jie, ZHAO Zhangkai, WANG Jianhong, CHANG Rumeng, YUAN Peng, LIU Jingyi, YANG Pan. Mechanism of Chinese Herb Angelica dahurica Preventing and Treating Osteoporotic Pain[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2022, 24(9): 850-855.

参考文献

[1]谢俊雄，申思敏，曹毅，等.骨质疏松性疼痛的管理及研究进展[J].中国疼痛医学杂志，2021，27(8)：611-615.
     [2]史计月，王金花，贺靖澜，等.骨质疏松疼痛病防控［M］.北京：清华大学出版社，2021：72.
     [3]于定荣，翁小刚，王本晓，等.延胡索、白芷炮制配伍对元胡止痛方中延胡索乙素、欧前胡素含量以及镇痛作用的影响[J].中草药，2021，52(8)：2306-2312.
     [4]徐方飚，王新志，孙田烨，等.基于网络药理学白芷香豆素类镇痛作用研究[J].中华中医药学刊，2021，39(3)：196-199.
     [5]Liu JH，Chen CY，Liu ZZ，et al.Extracellular vesicles from child gut microbiota enter into bone to preserve bone mass and strength[J].Adv Sci，2021，8(9)：200-218.
     [6]国家药典委员会.中华人民共和国药典：一部［S］.北京：中国医药科技出版社，2015：109.
     [7]葛继荣，王和鸣，郑洪新，等.中医药防治原发性骨质疏松症专家共识(2020) [J].中国骨质疏松杂志，2020，26(12)：1717-1725.
     [8]Zhang L，Yin X，Wang J，et al.Associations between VDR gene polymorphisms and osteoporosis risk and bone mineral density in postmenopausal women：a systematic review and Meta-analysis[J].Sci Rep，2018，8(1)：981-910.
     [9]Bonafe L，Cormier-Daire V，Hall C，et al.Nosology and classification of genetic skeletal disorders：2015 revision[J].Am J Med Genet A，2016，167A(12)：2869-2892.
     [10]章振林.基因突变与代谢性骨病[J].中国临床新医学，2018，11(12)：1177-1180.
     [11]金泯廷，郑洪新.骨质疏松症的中医体质学特征[J].中华中医药学刊，2009，27(4)：824-826.
     [12]杨粤戈，池晓玲.《内经》体质学说与现代体质学说差异探寻[J].时珍国医国药，2021，32(6)：1537-1538.
     [13]杨群政，章先锋，陈英，等.类风湿关节炎与骨质疏松症的关系研究[J].中医正骨，2021，33(2)：26-29.
     [14]冷子宽，寇红伟，刘宏建.骨质疏松基础研究的现状与展望[J].中华实验外科杂志，2021，38(7)：1189-1192.
     [15]李建国，谢兴文，李宁，等.绝经后骨质疏松症的中医脏腑认识及治疗现状[J].中国中医基础医学杂志，2019，25(3)：410-412,420.
     [16]Bouillon R，Marcocci C，Carmeliet G，et al.Skeletal and extraskeletal actions of Vitamin D：current evidence and outstanding questions[J].Endocr Ｒev，2019，40(4)：1109-1151.
     [17]Polzonetti V，Pucciarelli S，Vincenzetti S，et al.Dietaryintake of Vitamin D from dairy products reduces the risk of osteoporosis[J].Nutrients，2020，12(6)：1743-1752.
     [18]Mcphee JS，French DP，Jackson D，et al.Physical activity in older age：perspectivesfor healthy ageing and frailty[J].Biogerontology，2016，17(3)：567-580.
     [19]Beck BR，Daly RM，Singh MA，et al.Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis[J].J Sci Med Sport，2017，20(5)：438-445.
     [20]Tański W，Kosiorowska J，Szymańska-Chabowska A.Osteoporosis-risk factors，pharmaceutical and non-pharmaceutical treatment[J].Eur Rev Med Pharmacol Sci，2021，25(9)：3557-3566.
     [21]乔小万，邓强，李中锋，等.基于“肾虚髓枯”理论探讨骨质疏松症的病机及中药治疗[J].中国骨质疏松杂志，2022，28(5)：760-765，780.
     [22]刘立安，孟月，何寅家，等.疼痛类病症中医再识与扶阳疼痛学[J].中华中医药杂志，2022，37(4)：1978-1981.
     [23]Rousselle AV，Heymann D.Osteoclastic acidification pathways during bone resorption[J].Bone，2002，30(4)：533-540.
     [24]Abe Y，Iba K，Sasaki K，et al.Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice[J].J Bone Miner Metab，2015，33(2)：125-134.
     [25]Kanaya K，Iba K，Abe Y，et al.Acid-sensing ion channel 3 or P2X2/3 is involved in the pain-like behavior under a high bone turnover state in ovariectomized mice[J].J Orthop Res，2016，34(4)：566-573.
     [26]Chen H，Hu B，Lv X，et al.Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis[J].Nat Commun，2019，10(1)：181.
     [27]马海珍，祝华，陈娟，等.腰椎间盘突出对绝经后妇女骨密度的影响分析[J]. 中国骨质疏松杂志，2017，23(11)：1420-1424.
     [28]谭亚芹，马昕婷，王琦，等.国家标准《腧穴名称与定位》(GB/T 12346-2006)使用情况调查研究[J].中国针灸，2016，36(8)：871-874.
     [29]Ghaffari S，Abbasi A，Somi MH，et al.Akkermansia muciniphila：from its critical role in human health to strategies for promoting its abundance in human gut microbiome[J].Crit Rev Food Sci Nutr，2022，12(3)：1-21.
     [30]Floris F，Adriaan AB，Theo B，et al.Aged gut microbiota contributes to systemical inflammaging after transfer to germ-free mice[J].Front Immunol，2017，(8)：1385-1392.
     [31]Lerner A，Neidhofer S，Matthias T.The gut microbiome feelings of the brain： A perspective for non-microbiologists[J].Microorganisms，2017，5(4)：66-72.
     [32]Ejtahed HS，Soroush AR，Angoorani P，et al.Gut microbiota as a target in the pathogenesis of metabolic disorders：A new approach to novel therapeutic agents[J].Horm Metab Res，2016，48 (6)：349-358.
     [33]张媛，付志飞，覃小燕，等.肠道菌群对骨质疏松发生发展作用及中药干预影响[J].辽宁中医药大学学报，2020，22(11)：115-118.
     [34]Sylvester FA. Inflammatory bowel disease： effects on bone and mechanisms[J].Adv Exp Med Biol，2017，1033：133-150.
     [35]王春梅，崔新颖.白芷香豆素的镇痛机制初探[J].北华大学学报，2009，10(2)：121-123.
     [36]朱艺欣，李宝莉，马宏胜，等.白芷的有效成分提取、药理作用及临床应用研究进展[J].中国医药导报，2014，11(31)：159-162，166.
     [37]聂红，沈映君，吴俊梅，等.白芷挥发油镇痛、镇静作用和身体依赖性研究[J].中药新药与临床药理，2002，(4)：221-223，269.
     [38]崔胜楠，周智辉，李玮，等.白芷有效成分抗肿瘤作用机制研究进展[J].国际中医中药杂志，2018，40(4)：381-384.
     [39]刘磊，李薇薇，张国海.中医之“靶向治疗”[J].中医研究，2021，34(7)：9-13.
     [40]Johnson-King B，Terry SF.Future of microbiomes through the national microbiome initiative[J].Genet Test Mol Biomarkers，2016，20(10)：561-562.
     [41]Heintz-Buschart A，Wilmes P.Human gut microbiome： function matters[J].Trends Microbiol，2018，26(7)：563-574.
     [42]Locantore P，Del Gatto V，Gelli S，et al.The interplay between immune system and microbiota in osteoporosis[J].Mediators Inflamm，2020，25(9)：368-374.
     [43]Milani C，Duranti S，Bottacini F，et al.The first microbial colonizers of the human gut：composition，activities， and health implications of the infant gut microbiota[J].Microbiol Mol Biol Rev，2017，81(4)：36-47.
     [44]Li C，Pi G，Li F.The role of intestinal flora in the regulation of bone homeostasis[J].Front Cell Infect Microbiol，2021，11(6)：579-583.
     [45]蒋风茹，杭露，周盐，等.雌激素-肠道菌群相互作用与肠易激综合征[J].世界华人消化杂志，2022，30(12)：511-520.
     [46]Yan DY，Tang J，Chen L，et al.Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β-catenin pathways[J].J Cell Mol Med，2020，24(3)：2330-2341.
     [47]谭亮，王小娇，肖炜.欧前胡素通过提高自噬水平缓解大鼠雌激素缺乏性骨质疏松[J].基础医学与临床，2016，36(11)：1542-1547.

快速检索引用检索图表检索高级检索